Bayer: Co.Lab Shanghai inaugurated
(CercleFinance.com) - Bayer has announced the inauguration of its new life sciences incubator, Bayer Co.
Lab Shanghai, in the Shanghai Innovation Park (SH-INNO), in the heart of China's largest biopharmaceutical cluster, Zhangjiang, Shanghai.
Bayer Co.Lab is part of a global network of life sciences incubators located in key innovation centers, including Cambridge (US), Kobe (Japan) and Berlin (Germany).
The incubator will provide state-of-the-art laboratories, collaborative workspace and tailored support for start-ups, serving as a key pillar to advance local innovation across the biopharmaceutical value chain, it says.
With Bayer Co.Lab Shanghai, we provide access to Bayer's expertise in cell and gene therapy and oncology, and connect start-ups with our international innovation and partner networks in an ecosystem conducive to their growth and development, it said.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Lab Shanghai, in the Shanghai Innovation Park (SH-INNO), in the heart of China's largest biopharmaceutical cluster, Zhangjiang, Shanghai.
Bayer Co.Lab is part of a global network of life sciences incubators located in key innovation centers, including Cambridge (US), Kobe (Japan) and Berlin (Germany).
The incubator will provide state-of-the-art laboratories, collaborative workspace and tailored support for start-ups, serving as a key pillar to advance local innovation across the biopharmaceutical value chain, it says.
With Bayer Co.Lab Shanghai, we provide access to Bayer's expertise in cell and gene therapy and oncology, and connect start-ups with our international innovation and partner networks in an ecosystem conducive to their growth and development, it said.
Copyright (c) 2024 CercleFinance.com. All rights reserved.